Tag: AbbVie

Pharmaceutical giant AbbVie is making decisive moves that signal a significant evolution in its corporate strategy. The company recently achieved ...

Pharmaceutical giant AbbVie is demonstrating strategic agility as it shifts resources toward promising growth areas while exiting less productive ventures. ...

Investors in pharmaceutical leader AbbVie are navigating a period of significant uncertainty as the company approaches its third-quarter earnings release. ...

A substantial $2.7 billion charge has delivered a significant blow to biotechnology leader AbbVie, forcing the company to dramatically lower ...

A landmark legal settlement has fundamentally reshaped the long-term financial outlook for pharmaceutical giant AbbVie. The company has successfully safeguarded ...

A strategic legal agreement has positioned pharmaceutical giant AbbVie for exceptional financial performance through the next decade. In a development ...

While broader markets posted gains in the latest session, AbbVie Inc. shares demonstrated a more measured performance. Behind this surface ...

AbbVie stunned investors with stronger-than-expected quarterly results, driven by explosive growth in its immunology drugs Skyrizi and Rinvoq, which more ...